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Abstract 
BACKGROUND: Hydrofluoric acid is a commonly used chemical in many industrial branches, but it can also be 
found as an ingredient in household products such as cleaning agents. Possessing high corrosive potential, HF 
acid causes burns and tissue necrosis, while when absorbed and distributed through the bloodstream, its 
extremely high toxic potential is expressed. Acute symptoms are often followed by pain, particularly in the case of 
skin burns, which intensiveness does not often correlate with the expressiveness of the clinical findings. Even 
exposure to low-concentrated solutions or gasses, or low-doses of high-concentrated acid, may provoke delayed 
systemic disorder which may eventually have a lethal outcome.  
AIM: Therefore, having information regarding the possible hazardous effects of hydrofluoric acid usage, a variety 
of symptoms, as well as a treatment approach, is of great importance in the case of HF exposure.  
METHODS: Available scientific articles published in literature databases, scientific reports and governmental 
recommendations from the internet websites, written in English, using the following search terms “Hydrofluoric 
acid, skin burns, eye injury, ingestion, inhalation, systemic toxicity, decontamination, antidote, medical treatment” 
have been reviewed.  
RESULTS: This review is useful not only for physicians but for everyone who may come in contact with a person 
exposed to HF acid.  
CONCLUSION: It highlights the mechanism of action, presents the acute and chronic symptoms, personal and 
general protective measures and devices that should be used, as well as decontamination procedures, 
immediate, antidote and hospital medical treatment. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Hydrofluoric acid as a chemical compound 
with a high reactivity is used in many industrial 
branches: fluorine industry, glass industry, 
stevedoring and transportation industries, 
semiconductor industry, stainless steel and aluminum 
manufacturing, electronic components manufacturing, 
metal finishing and metal rust removal industry, 
inorganic and organic chemical manufacturing, 
mineral processing, petroleum refining, fire 
extinguishers manufacturing, as well as waste and 
disposable service sectors [1], [2], [3], [4], [5]. In the 
dental industry and every-day clinical practice, HF 
acid is used as an etchant agent for ceramic materials 
[6], [7], [8]. Hydrofluoric acid can be found in 
consumer products for marble, brick and stone 
cleaning, as a rust removal, in automobile wheel 
cleaners, toilet bowl cleaners, air conditioners 
cleaners, and as insecticides [9], [10], [11], [12], [13], 
[14].  
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Unintentional exposure to hydrofluoric acid or 
gases, with health consequences, may occur in case 
of inappropriate operation, inadequate protection, 
when having machine problems, explosion of HF 
containers and tanks, during the traffic accidents [1], 
and inattentive usage of household agents [10], while 
intentionally, in case of suicide [11], [12], [14] and 
murder. There are cases of intoxicated children when 
domestic cleaners, in appropriately stored, were 
accidentally ingested [13]. 
Dermal burns, eye injury and gastrointestinal 
or respiratory acute symptoms may be provoked when 
in direct skin/eye contact with HF acid, ingestion of the 
solutions or inhalation of fumes or HF vapours. 
Systemic intoxication including electrolytic 
misbalance, enzyme inhibition, cardiovascular, 
pulmonary, renal and neuromuscular symptoms 
happens when fluoride ions are absorbed into the 
bloodstream after dermal exposure and other mucous 
membranes, and distributed in all tissues and organs. 
Chronic symptoms may even occur several months 
after HF ingestion [12] or may persist with months 
after the long-time respiratory exposure [3]. 
Sometimes, systemic intoxication has a lethal 
outcome [15], [16], [17], [18], [19], [20].  
The tissue damage and the degree of toxicity 
are determined by the acid concentration, the 
exposure time, the contaminated body surface area, 
the time elapsed between exposure and 
decontamination i.e. hospital care [21], [22], [23], and 
person’s age as well [13], [24].  
Decontamination, antidote therapy and 
hospital treatment, implemented promptly, are of great 
importance to prevent penetration of the hydrofluoric 
acid deep into the tissue, to disable dissemination of 
the fluoride ions through the bloodstream, or to 
minimise the progression of organs’ damage.  
The purpose of this review is to present the 
properties of a hydrofluoric acid, its corrosiveness, 
toxicity and mechanism of action, acute and chronic 
symptoms after the HF exposure, describes 
preventive and protective measures, as well as 
procedures for decontamination and HF 
neutralisation, antidote and hospital medical 
treatment.  
 
 
HF Acid Properties 
 
Hydrogen fluoride (HF) has several 
synonyms: Hydrofluoric acid, Fluoric acid, 
Hydrofluoride, Fluorine monohydride, Fluorane. 
Physical properties: As a gas, HF is a 
diatomic compound of hydrogen and fluorine atoms, 
while as a liquid, it is a polymeric compound with 
strong hydrogen bonds between the chains [8]. Both, 
anhydrous hydrofluoric acid and aqueous solutions 
are colourless, fuming gas or liquid with a strong, 
irritating odour. Its disagreeable, pungent odour, even 
at the concentration of 0.04 ppm (which is 
considerably less than the OSHA PEL - Permissible 
Exposure Limit of 3 ppm), is a warning sign of the 
presence of the potentially dangerous substance. It 
readily dissolves in water forming a colourless 
hydrofluoric acid solution that when diluted 
(exothermal reaction) is visibly indistinguishable from 
water [4], [24], [25], [26].  
Some of the physical properties of the 
Hydrofluoric acid are presented in Table 1. 
Table 1: Physical properties of the hydrofluoric acid 
Molecular Formula:  
Molecular Weight:  
Boiling point:  
Freezing Point: 
Specific gravity: 
Density: 
Vapour pressure:  
Vapour density:  
Surface Tension: 
pKa*:  
The heat of Vaporization: 
Solubility:  
 
Flammability: 
HF 
20.006 g/mol 
20 °C (68°F) at 760 mm Hg 
-83 °C (-117.4 °F) 
0.99 at -7 °C (19,4 °F); 1 for liquid at 20 °C (68 °F) (water = 1) 
1.002 at 0 °C / 4 °C 
783 mm Hg at 20 °C (68 °F); 400 mmHg at 2.5 °C (36.5 °F)  
1.27 at 34 °C (air=1) 
10.2 mN/m at 0 °C 
3.15 
7.493 KJ/mol at 101.3 KPa 
Miscible with water, very soluble in alcohol,  
soluble in many organic solvents 
Nonflammable, explosive or oxidising 
*acid dissociation constant  
 
Chemical properties: Hydrofluoric acid is 
characterised by high reactivity - it reacts with metals, 
glass, concrete, enamels, pottery, rubber, leather and 
many organic compounds [24], [25], [26]. 
Consequently, it is commonly used in many industrial 
sectors and as a domestic cleaning agent. HF has a 
unique ability to react with many silicon compounds, 
including glass [9], thus commonly used as an etchant 
agent in the glass industry and before adhesive luting 
of ceramic restorations in dentistry [27].  
 
 
Preventive Measures when Working with 
Hydrofluoric Acid 
 
Because of its high corrosiveness and toxicity, 
the extraordinary caution when using is 
recommended. Hydrofluoric acid should be 
exclusively used inappropriately equipped industrial 
sectors and laboratories, must not be applied on the 
restorations in the oral cavity (when used in dentistry), 
while attending, when using household and cleaning 
agents, is recommended. The last one should be 
stored out of reach of children. Personal and general 
protective equipment and measures should be 
implemented. 
The person who uses HF acid should be 
aware of the toxicity of this agent and be familiar with 
all information and procedures regarding the safety 
when using, way of transporting and storing the acid, 
managing with HF containing waste, decontamination 
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procedures, antidote and medicaments that should be 
used in case of contact and intoxication [4], [5], [24], 
[25], [26], [27]. Protective equipment and measures, 
as well as managing with HF containing waste and 
spills are presented in Table2. 
Table 2: Personal and general protective equipment and 
measures, medicaments used in the first aid kit, and managing 
HF containing waste and acid spills 
Personal Protective Equipment 
when working with/using HFA 
General Protective Equipment 
at the working/laboratory place 
 
Laboratory coat 
Long pants 
Acid resistant apron 
Close-toed shoes 
Tightly sealed goggles  
Full-face shield in conjunction with goggles  
Rubber gloves: nitrile, butyl or neoprene  
Respiratory filter device 
Handled inside of a fume hood 
Ventilation/exhaust system  
Sign “Danger, Hydrofluoric Acid Used in this 
Area.” 
Easy access to a good supply of running 
water  
Safety shower and eyewash  
The Standard Operating Procedure (SOP) 
document 
Protective Measures 
HFA containers  
First aid kit 
medicaments 
Polyethylene or Teflon  
Clearly labelled  
Securely supported and not likely to tip 
over  
Tightly closed and kept in a safe place 
Away from heat and direct sunlight  
2.5% calcium gluconate gel 
1% calcium gluconate eyewash
  
a solution of 0.13% benzalkonium chloride  
Managing HF Containing Waste Managing HF Acid Spills  
Neutralisation of the solution using powder: 
Na2CO3, Ca2CO3 
Neutralised diluted solution should be 
disposed under running water 
Chemically resistant container, clearly 
labelled with a “Hazardous Waste” tag 
HF-specific absorbents  
Aqueous Ca(OH)2 or Mg(OH)2 
The neutralisation should be performed slowly 
to avoid an exothermic reaction that will speed 
up the evaporation of the HF and increase the 
risk of exposure and intoxication 
 
 
Corrosiveness and Toxicity  
 
Hydrofluoric acid is characterised by its 
corrosiveness and high local and systemic toxicity. At 
room temperature (20°C), it has a strong acidic pH-
value of 2.0 [27]. However, the devastating effects are 
not based on the low pH value, but on the toxicity of 
this acid [9], [21], [22].  
Routes of exposure: There are three 
different pathways through which HF acid could be 
absorbed into the human body - skin/eye contact, 
inhalation and ingestion. The most frequent exposure 
is by cutaneous contact with the aqueous solution, no 
matter if the skin is intact or damaged [28], [29], [30], 
[31], [32]; it could also be absorbed through eyes [33], 
[34]. Inhalation intoxication occurs not only from 
exposure to hydrogen fluoride gas [17], [35], but also 
from vapors arising from concentrated hydrogen 
fluoride liquid [20], [36], while ingestion [14], [37], [11] 
of even a small amount of this acid is likely to produce 
systemic effects and may be fatal [13], [16], [18], [38], 
[39].  
Mechanism of action: Easy penetration 
through the skin, soft tissues and lipid membranes are 
enabled by low charging of undissociated hydro 
fluoride molecules. Once in the tissue, the HF 
molecules dissociate in hydrogen cations and fluoride 
anions [9].  
There are two primary mechanisms through 
which HF acid causes tissue destruction. The first 
occurs due to the activity of corrosive hydrogen ion 
when using a high concentration of this acid (>50%) 
and is associated with cutaneous and ocular lesions, 
as well as digestive and respiratory mucous 
membrane damage. Corrosive burns are similar to 
those provoked by other acids: they occur 
immediately, with visible tissue destruction, grey 
areas, ulceration or necrosis, followed by intense pain 
[9].  
The latter is caused by cytotoxic fluoride 
anion responsible for local and systemic toxicity when 
HF acid products with high, as well as with low 
concentrations have been used [23], [40]. The fluoride 
ion is very small and diffuses readily in the aqueous 
media [9]. Absorbed into the bloodstream, it is carried 
to all body organs in proportion to their vascularity and 
fluoride concentration in the blood [16], [41]. When 
reacting with cellular calcium and magnesium, forms 
insoluble chelates, CaF2 and MgF2, thus provoking 
local calcium depletion and inhibition of Na
+
K
+
 ATP-
ase pump. Subsequently, the cell membrane’s 
permeability to potassium is increased resulting in 
local hyperkalemia. High lipid affinity induces 
liquefaction necrosis and cellular death, thus 
destructing the nerve and blood vessels, tendons, 
bone structures and all other tissues [23],[42]. These 
effects are due to the presence of fluoride ion and 
differ from other acids, in which the feature of the free 
hydrogen cations to provoke coagulative necrosis, 
which retards the further penetration into the tissues, 
is expressed [9], [11].  
Fluoride Distribution: Deposition of the 
fluoride in the different tissues is characteristic: as the 
fluoride is excreted through the urine, after an acute 
exposure to fluoride-containing solutions, the most of 
the fluoride is deposited in the kidney, then in the liver 
and the spleen; insignificant amount has been 
detected in the bones [16]. Rapid excretion and 
removal of the fluoride from the kidney occur within 24 
hours [43]. However, after chronic exposes, a large 
amount (about half of the dose) is deposited in the 
bones, while the kidney serves as a temporary 
depositing organ.  
Referential exposure limits: Systemic 
effects are potentially lethal, depending on the acid 
concentration and available amount of free fluoride 
ions [44]. Referential exposure limits and HF burns 
with a high risk to develop lethal electrolyte 
imbalances are presented in Table 3 [4], [24]. 
Special attention should be paid if intoxicated persons 
are children [13]. Because of their relatively larger 
surface area: body weight ratio, children are more 
vulnerable to the hydrofluoric acid absorbed through 
the skin. When exposed to its evaporations, larger 
doses are inhaled because of greater lung surface 
area: body weight ratio and increased minute 
ventilation per kg weight compared to adults. 
Additionally, vulnerability to corrosive agents is 
greater because of the relatively smaller diameter of 
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their airways [5], [24], [25]. 
Table 3: Exposure limits and HF burns that occupy various 
BSA depending on the acid concentrations that could have a 
lethal outcome 
Exposure limits 3 ppm
*
 - maximum concentration of a chemical substance that 
an employee may be exposed to over an 8-hour work shift; eyes 
and throat irritation, if not protected, have been noted.  
 
20 ppm
**
 - maximum airborne concentration below which it is 
believed that nearly all individuals could be exposed for up to 1 
hour without experiencing or developing irreversible or other 
serious health effects or symptoms, which could impair an 
individual’s ability to leave the contaminated area, and take 
protective action.  
 
30 ppm
***
 - immediately dangerous to health or life 
concentration. 
 
 
HF burns with a high 
risk to develop lethal 
electrolyte imbalances 
 
1% BSA burn with anhydrous HF 
5% BSA burn with >70% concentrated HF 
7% BSA burn with 50–70% concentrated HF 
10% BSA burn with 20–50% concentrated HF 
20% BSA burn with <20% concentrated HF 
Prolonged exposure or long delay for treatment in minor HF 
burns 
Ingestion of HF at concentrations >5% 
Inhalation of HF at concentrations >5% 
allowed by OSHA
*
; according to AIHA
**
; established by NIOSH
***
*1%, BSA is an area 
equal to a hand palm. 
 
 
Symptoms 
Dermal exposure: Skin burns  
A 10-year [1], a 11-year [20], a 15-year [30], a 
20-year [2] and a 22-year [29] retrospective 
epidemiological studies revealed that chemical burns 
encountered in a Burn centres caused by hydrofluoric 
acid are one with the most frequent occurrence, 
especially in the regions with highly developed 
industry. The most common sites of injury are the 
head and neck, hands, legs and arms [1], [45]. HF 
burns might be accompanied by ocular injuries, 
respiratory and digestive tract disorders [1].  
Transdermal penetration of the fluoride ions 
depends on the exposure time and HF acid 
concentration, while intradermal accumulation is dose-
dependently. Fluoride penetration increases four-
times by extending the exposure time from 1 to 3 min 
(with no further increase when the exposure is 
prolonged to 10 min) and is exponentially increased 
with increasing the HF concentration from 5% up to 
50%. Also, intradermal pH decreases with increasing 
the HF concentration and exposure time [46]. 
Accordingly, epidermal alterations can be detected 
after 3 min exposure to only 5% HF. Severe damage 
including coagulation necrosis of deeper dermal 
layers is provoked by HF concentration of ≥ 30%, with 
a considerable intradermal accumulation of 13-67% of 
total absorbed fluoride [47].  When exposed to 70% 
HF for only 20 sec, cellular alteration in four to five 
epidermal layers is noted by 1 min after the exposure. 
Within 5 min, HF acid completely penetrates to the 
human dermis [44], [48]. Coagulation necrosis 
including acidophilic cellular cytoplasm and pyknotic 
nuclei in all skin layers have been detected 1 h after 
exposure, while complete necrosis of the epidermis 
and disintegration of the structures have been 
observed by 24 hours [49].  
Further penetration of the fluoride ion through 
all epidermal and dermal layers into the subcutaneous 
tissue, causes ulceration and severe destruction such 
as complete loss of the soft tissues on the place of 
contact, including myolysis, tenosynovitis, 
decalcification and osteolysis [4], [9], [32], [50].  
Skin damage symptoms are directly related to 
the acid concentration. Strong concentrations of more 
than 50% HF acid cause immediate, severe, throbbing 
pain and a whitish discolouration of the skin [51], 
vesicle surrounded by an erythematous flare [52], 
which eventually transforms into the blisters 
containing necrotic tissue. Reduced motor activity, 
decreased sensitivity and ischemia provoked by 
arterial vasospasm might be additional symptoms in 
fingers’ burns [53]. Necrotic dermal tissue detached 
from the subcutaneous tissue has been observed in 
third-degree skin burns provoked by 50% HF acid 
[19].  
An autopsy finding of a man who died from a 
cardiopulmonary arrest 30 min after the exposure to 
60% HF acid, with the skin burns that occupy 30% of 
the TBSA, revealed greenish-gray or black coloring 
skin with thin circumferential erythema and severe 
liquefaction necrosis, with completely lost elastic 
fibers within the dermis, and severely affected wall of 
large vessels within the subcutaneous layers. 
Immediate penetration of the fluoride ions into the 
deep layer of the skin and their rapid dissemination 
through the bloodstream resulted in the development 
of acute systemic toxicity with the lethal outcome [15].  
Dilute solutions from 20% to 50% may 
provoke pain and swelling, with erythema and vesicles 
formation on the contact area, which may be delayed 
up to 8 hours [21].  
Acid solutions with concentration lower than 
20% may cause serious injury (deep burns and tissue 
necrosis) 12 to 24 hours or several days after the 
exposure, without immediate pain [9], [22], [23], [32], 
[42], [54].  
The severe pain, that is the first symptom of 
an intensive HF burns, results from the neuronal 
depolarization, disruption in neuronal conductivity and 
nerve ending irritation provoked by hyperkalemia in 
extracellular spaces, a compensatory mechanism for 
reduced levels of calcium ions which have been 
bound by the fluoride [23], [28], [40]. In case of burns 
provoked by low-concentrated HF acid, the onset of 
pain is a result of the long lag time in pH drop [46]. 
 
Ocular exposure: Eye burns 
Irritation and immediate severe pain, followed 
by lacrimation are first signs after eye exposure. 
Conjunctivitis followed by oedema and congestion 
[45], oedema of other structures of the eye, mydriasis, 
nystagmus, and corneal erosion and ulceration, with 
corneal opacification and non-visible iris as 
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complications, may result from even minor 
hydrofluoric acid splashes [33], [55]. Prolonged HF 
exposure can lead to loss of vision and total eye 
destruction. Ocular burn with a complete diffusion into 
the cornea has been detected within 4 min exposure 
to 2.5% HF acid [48].  
 
Gastrointestinal exposure 
Ingestion of a solution of hydrofluoric acid 
[13], [14], [37], [38], causes strong caustic effect on 
the mouth and throat, erythema, ulcerations and 
bleeding of the oral mucosa, with the risk of 
perforation of the esophagus and/or stomach, erosive 
gastritis [16] followed by severe abdominal pain, 
dysphagia, nausea, vomiting and diarrhea, that 
eventually may progress to hemorrhagic gastritis, 
hematemesis and melena [11], [12], [39], [41]. Liver 
congestion, hepatocellular swelling and pancreatitis 
may also be present [16].  
An autopsy finding of a person who 
accidentally ingested a mixture of 
hydrochloric and hydrofluoric acid revealed 
haemorrhages in the gastrointestinal tract, brownish 
discolouration of the oesophagal, gastric, duodenal 
and small intestinal mucous membranes with necrosis 
foci reaching the deeper layers of the walls, numerous 
ulcerations in the oesophagus and the stomach, and 
congested mucous membrane of the large intestine 
[18].  
 
Respiratory exposure 
Symptoms from respiratory system may occur 
when exposed to HF gas, fumes or vapours which 
arise when liquid acid evaporates on increased 
ambient temperature; in the case of a pulmonary 
aspiration while ingesting [1]; as a systemic toxicity 
symptom after HF acid ingestion [16], [18]; as a 
respiratory complication after HF splashes on the skin 
[24], or after severe dermal burns [45].  
The toxicological effect of HF gases or 
vapours on the airway epithelia depends on the 
inhaled doses: when exposed up to 1.5 mM HF, no 
toxic effect has been observed; repairable damage to 
the epithelial cells has been detected when inhaled 
7.5 mM HF, while severe, irreversible damage has 
been caused by 75 mM inhaled HF gas [48].  
Inhalation of toxic gases or vapours provokes 
nasal irritation and inflammation, dryness and 
mucosal bleeding with subsequent ulceration and/or 
perforation of nasal septum, erythema and oedema of 
the oral, nasal end laryngeal mucous membrane. 
Continued exposure can results in coughing, dyspnea, 
laryngitis, laryngospasm and retrosternal pain, 
followed by chills, fever, and cyanosis [5], [56]; it has a 
devastating effect on the trachea and bronchi causing 
tracheobronchitis, bronchiolar obstruction [10] and 
bleeding accompanied by stridor and wheezing. 
Gaseous HF when reaches the pulmonary tissue 
provokes pulmonary oedema and congestion, pleural 
effusion, pneumonia [16], [57], and even partial or 
complete lung collapse [9], [40]. Chest radiograph 
revealed pulmonary oedema [57] or diffuse infiltrative 
shadows over the lungs’ parenchyma [35], [56]. Acute 
respiratory failure may even lead to a lethal outcome 
[20] with little to no additional signs of trauma [17]. 
Chronic, repeated exposure to hydrofluoric acid-
containing fumes may provoke pulmonary alveolar 
proteinosis followed by long-lasting dyspnea [3]. 
The presence of pale bronchial mucus on the 
bronchial membrane and congested, edematous 
mucosa several days after skin exposure have been 
confirmed by fiberoptic bronchoscopy [45]. 
Extravasations and hemorrhagic infarcts have been 
detected in the lungs after fatal accidental ingestion of 
a mixture of hydrochloric and hydrofluoric acid [18]. 
 
Systemic poisoning 
Absorption of the fluoride ions into the 
bloodstream after dermal HF exposure, ingestion, or 
inhalation, and their distribution in all cells [16] may 
result in systemic toxicity [28]. The degree of toxicity 
and the outcome depends on the HF concentration 
and duration of exposure, burn surface area and burn 
depth, and the time elapsed between exposure and 
decontamination/medical treatment [15], [45].  
When exposed to diluted solutions or low-
saturated gas, the symptoms are often delayed. Even 
a severe dermal burns provoked by concentrated HF 
acid with symptoms of systemic poisoning, when 
treated in timely manner with appropriate therapy, 
may have favorable outcome, as in the following 
cases: face and neck exposure to 100% HFA [56], 
[57], skin burns provoked by 71% HFA occupying 
7%TBSA [58], skin burns provoked by 70% HFA 
occupying 10%TBSA [59], face and neck exposure to 
53% HFA [60].  
Cases with expressed systemic disorder 
including electrolyte imbalance, enzyme inhibition, 
symptoms of hypovolemic shock, multiorgan failure, 
acute respiratory failure and numerous ventricular 
fibrillation or asystole, in which resuscitation 
procedures have been ineffective, have a lethal 
outcome [15], [18], [19]. 
 
Laboratory findings 
Due to the high affinity of fluoride ion towards 
calcium and magnesium, and formation of insoluble 
salts, massive systemic electrolyte imbalance, which 
is difficult to counterbalance, may occur [53], [60]. 
This includes hypocalcemia, hypomagnesemia [45], 
hyperkalemia [14], [15], [19] or hypokalemia [2], [61], 
[62], fluorosis and metabolic acidosis [1], [19]. 
Enzyme inhibition and coagulation disorders [15], [22] 
are common findings as well.  
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Cardiovascular system disorder 
The electrolytic imbalance affects the 
cardiovascular system, provoking hypotension and 
vasospasm [53], [63]. Hypocalcemia causes 
decreased myocardial contractility and intermittent 
prolongation of the Q-T interval, which is associated 
with degenerative rhythms such as torsades de 
pointes, a specific type of ventricular tachycardia that 
may cause sudden death. Hypomagnesemia is also 
associated with prolonged QTc and lethal 
dysrhythmias [9], [14], [38]. Moderate hyperkalemia 
can cause ECG changes, while severe hyperkalemia, 
due to the suppression of the electrical activity of the 
myocardium, may cause cardiac arrest. Additionally, 
free fluoride ions activate myocardial adenylyl cyclase 
thus increasing cyclic adenosine monophosphate 
(cAMP), which stimulates the myocardium inducing 
refractory ventricular fibrillation. Severe fluoride 
intoxication may provoke sudden cardiac arrest with a 
lethal outcome [1], [2], [13], [16], [18], [19], [23]. 
Recurrent ventricular dysrhythmias [14] or 
asystolia [62] can be developed several hours after 
HF acid ingestion or dermal exposure, while 
congestive heart failure provoked by toxic myocarditis 
has been detected as a long-term complication, four 
months after the hydrofluoric acid ingestion [12].  
 
Renal symptoms 
Fluorosis causes renal dysfunction, 
insufficiency and renal cortical necrosis followed by 
hematuria, proteinuria and azotemia [9], [15], [19], 
[22]. 
 
Osteosceletal symptoms 
As the significant amount of fluoride deposits 
in the bones, osteolysis caused by HF intoxication has 
been observed. 
 
Neuromuscular symptoms 
Intoxication caused by acute exposure to HF 
acid may influence the function of the neuromuscular 
system. Hypocalcemia and hyperkalemia cause 
depolarisation of nerves and muscle fibres and 
interfere with the normal transmission of electrical 
signals throughout the neurons. The intoxicated 
person may become anxious, confused with 
headaches, may have seizures, paresthesia, paresis 
and paralysis [9], and may develop carpopedal and 
generalised tetany. When exposed to high doses, 
brain oedema followed by deep coma may occur [15], 
[16], [19].  
  
 
 
Immediate, Decontamination/ 
Neutralization Procedures and Hospital 
Medical Treatment of the HF-Exposed 
Person 
 
Correct diagnosis and timely treatment are of 
great importance when one is exposed to HF acid. 
Before starting any procedure, the exposed person 
should be checked for regular respiration and pulse, 
and in the case of suspected trauma, cervical 
immobilisation with a cervical collar and a backboard 
should be conducted. Decontamination implemented 
within the first minute and topical treatment including 
the use of the antidote is a critical procedure to 
prevent or minimise on-going HF absorption and 
progressive tissue destruction caused by fluoride ions 
[44].  
Sometimes, systemic support by qualified 
medical staff should be obtained [54]. Immediate 
transport to the hospital is mandatory for the 
decontaminated person who has been in contact with 
the concentrated HF acid solutions/ vapours, if 
exposure to the low HF concentration lasted longer, 
still having acute symptoms or systemic complications 
are expected (no matter of the route of exposure). 
During the transport, skin and eye irrigation should 
continue, assistant ventilation if breathing has stopped 
and cardiopulmonary resuscitation (CPR) in the case 
of cardiac arrest should be given. The person who has 
been exposed to HF fumes only, and does not have 
any symptoms of skin/eyes burns, should be 
transported to the hospital as well and held for 
observation for at least 24 hours, the period when 
swelling of the respiratory tract is expected 
[24],[25],[26].  
 
Treatment of the HF skin burns 
Decontamination is mandatory for the victims 
with the dermal or ocular contact; contaminated 
clothing, as well as jewellery that could trap HF, 
should be immediately removed and double-bagged 
[31]. There are several methods that can be used for 
decontamination and neutralisation of the exposed 
skin and hair: rinsing with water, saline or solution of 
soap and water, and neutralisation performed with 
calcium gluconate, benzalkonium chloride, 
polyethylene glycol, magnesium oxide or 
Hexafluorine. 
Rinsing with cold or warm (16°C) running 
water [29], [31], [33], [45], [51], [56], [59] or saline, for 
at least 30 minutes is the most commonly used 
decontaminating procedure. A solution of soap and 
water which should have a pH value of at least 8 
(should not exceed a pH value of 10.5), is also 
recommended to neutralise low pH of the HF acid 
[52], using a soft brush and moving in a downward 
motion (from head to toe). Five per cent solution of 
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sodium bicarbonate can be successfully used as well 
[45]. Rinsing should be thoroughly performed until the 
contaminant is removed [4]. Ice pack on the affected 
area may reduce symptoms by vasoconstriction it 
provokes and retarding diffusion of the ion into the 
bloodstream [4]. Special attention should be paid 
when decontaminating children or the elderly because 
of the risk of hypothermia (blankets or warmers may 
be used) [4], [24].  
Calcium gluconate (CaG) in its various 
formulations (solution, gel or ointment), administered 
immediately, is used as the most appropriate antidote 
when one is exposed to hydrofluoric acid. Sterile 
gauze moistened with 10% solution of calcium 
gluconate may be used to cover burn areas [45]. 
When used as a gel, 2.5 % CaG should be applied 
and rubbed into the affected area for 15-30 minutes 
[25], [40], wearing a new pair of chemical resistant 
gloves in order to prevent possible secondary HF 
burns [26]; upon reaction with the acid and forming 
CaF2 precipitate, CaG gel turns white. The gel should 
be re-applied, every 10-15 minutes until the 
ambulance arrives or a physician gives medical 
treatment [26]. If used as a definitive treatment, 2.5% 
calcium gluconate should be applied 4 to 6 times 
daily, for 3 to 4 days [24]. Used as an ointment, it 
should be applied every two hours [51]. Application of 
surgical jelly consisting of 50% calcium gluconate and 
50% dimethyl sulphoxide is recommended as well 
[29].  
An iced solution of 0.13 % benzalkonium 
chloride can be used for immersion or as soaked 
compresses for at least 2 hours (a total of 4 to 6 
hours); compresses should be changed or soaked 
with additional solution approximately every 2 to 4 
minutes [5], [49]. This solution should not be used for 
burns of the face, ears or other sensitive areas. 
Other useful agents are polyethylene glycol, 
magnesium oxide [59], 5% sodium bicarbonate [45], 
and Hexafluorine solution [48], [64]. 
Different agents have different ability in skin 
decontamination, neutralisation of the fluoride ion and 
minimising on-going HF absorption. According to 
Dennerlein et al. [65], polyethylene glycol reduces the 
cumulative penetrated amount of fluoride in the skin 
by 28%, flushing with water by 49%, while rinsing with 
CaG or Hexafluorine
©
 is the most effective method 
with a reduction rate of 64% [65]. 
Rinsing the 20-sec exposed skin to 70% HF, 
with running tap water for 15 min followed by one 
topical application of 2.5% CaG gel, has limited 
preventive effect over the integrity of the cellular 
structure in the epidermis and the papillary and 
reticular dermis. Recovery, after the initial cellular 
deteriorations, observed 1h after the exposure, turned 
into edematous changes in the epidermal basal layer 
3 hours later. No deterioration of the structures of 
either the epidermis or dermis have been detected 
after washing the exposed skin with Hexafluorine 
applied as a spray of 400 ml over 10 min, whatever 
the time of observation was [49].  
Hultén et al. [66] have not observed any 
differences in the electrolyte misbalance after dermal 
exposure to HF acid, between the Hexafluorine-
treated animals and those treated with water only. 
Further on, Brent [67], reviewing the data from 69 
relevant papers, concluded that water-based solutions 
are the best, widely available and inexpensive 
decontaminating fluids for dermal corrosive exposures 
[67]. However, Yoshimura et al. [59], concluded that 
even after a 3 hours delay, skin washing with 
Hexafuorine (followed by intravenous, intradermal, 
perilesional, and topical injunction of calcium 
gluconate) is beneficial in the treatment of first- to 
third-degree skin burns occupying approximately 10% 
of the TBSA, provoked by 70% HF. Decontamination 
with Hexafuorine has prevented the development of 
significant systemic toxicity which otherwise occurs 
when exposed to concentrated HF acid and often 
results with a fatal outcome [59]. 
Different neutralising abilities of agents are 
due to the different mechanism of action. Water has a 
mechanical rinsing and a diluting effect only; it has no 
active binding or chelating properties for any chemical 
substance, including hydrofluoric acid. As a hypotonic 
liquid, it cannot stop penetration of HF throughout skin 
layers and may enhance such penetration. Besides 
mechanical rinsing of the surface, a residue of fluoride 
ion might be still present on the skin in a sufficient 
quantity to provoke secondary necrosis.  
Unlike water, calcium gluconate is capable of 
chelating the free fluoride ions, forming insoluble salts, 
thus neutralising their toxical effect over the cells’ 
metabolism. A single application of CaG gel helps in 
delaying the onset of the skin injury and mitigating the 
severity of the damage, but the tissue lesions continue 
to evolve; this is the reason for recommendation, CaG 
gel to be applied multiple times [49].  
Hexafluorine® has a triple effect over the HF 
acid-exposed skin, eye or mucous membranes. As a 
sterile water-solution, it has the same rinsing and 
diluting effect as the pure water has. As an 
amphoteric compound, Hexafluorine actively acts 
against both primary mechanisms (corrosive and 
cytotoxic) through which HF acid causes tissue 
destruction: it has a property to neutralise the H
+
 ion 
and chelates the F
−
 ion. Consequently, 
decontamination with Hexafluorine® completely 
prevents cutaneous and eye tissue injuries [49], [64].  
Vapour burns of the skin are treated the same 
as liquid HF burns [36]. 
Hydrogen fluoride burns are followed by 
intense pain that should not be suppressed with local 
infiltration of anaesthetic because the degree of pain 
is an indicator of treatment efficacy.  
Topically applied, calcium gluconate has 
limited ability in term of chelating the F− ions that have 
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been already penetrated deeply into the skin tissues. 
In the case of large and/or deeply penetrating burns, 
when exposed to hydrogen fluoride concentrations 
greater than 50%, when the treatment is delayed, or if 
pain-relief is not achieved by previously applied CaG, 
subcutaneous injection of sterile aqueous calcium 
gluconate solution underneath the burned area and 
into the immediately adjacent skin should improve the 
neutralizing efficacy [29], [30], [52], [59], [68]; the 
recommended dose is limited to 0.5 mL/cm
2
 affected 
skin surface area of a 5% or 10% calcium gluconate 
solution (with a maximum of 0.5 mL per digit for finger 
burns), using a small gauge needle (#30) [29]. 
However, multiple injections into the fingers may lead 
to increased tissue pressure thus worsening an 
existing swelling, impairing circulation and causing 
ischemic necrosis [69]. It is recommended 
subcutaneous injection to be applied, only if there is a 
central grey burn with surrounding erythema, or when 
having severe throbbing pain [70].  
According to De Capitani et al. [51], “intra-
arterial calcium gluconate might be considered for 
finger burns caused by highly concentrated HF, when 
topical treatment is considered useless, or when 
intradermal and subcutaneous calcium injections 
cannot be performed” [51]. 
Calcium gluconate gel is not effective in 
treating burns of the nails as well. It may be necessary 
to drill, split or even remove nails to allow the topical 
methods of treatment to be effective [29], [30], [68]. 
Sometimes, removing the nails may be avoided by 
immediate immersion in benzalkonium chloride 
(Zephrian®) solution [24], [25]. 
The skin blisters, if already formed, should be 
opened and necrotic tissue should be debrided as 
soon as possible, as early debridement may facilitate 
healing [59]. There are several chirurgical methods 
which can be used for the treatment of the severe HF 
dermal burns: escharotomy or fish-mouth fasciotomy 
followed by intravenous administration of 
prostaglandin in order to maintain maximal distal 
circulation [71], succeed by skin grafting (a split-
thickness or full-thickness skin grafting) or flap 
transfer for wound closure and reconstruction [1]. In 
case of deep layer finger injuries of weight bearing 
portions such as finger pulp, a partial toe pulp-free 
flap should be performed to reconstruct the digits [71]. 
 
Treatment of the eye burns 
 After ocular exposure or irritation, the eyes 
should be immediately irrigated with a large amount of 
gently flowing cool plain water or sterile 0.9 % saline 
solution for 15-30 minutes [45], while holding eyelids 
apart, and moving the eyeball in every direction, thus 
ensuring the irrigator reaches all the surfaces. If the 
exposed person is wearing contact lenses, the lenses 
should be carefully removed [5], [24], [26]. If sterile 
1% calcium gluconate solution is available, water 
washing may be limited to 5 minutes. 
 Usage of 1-10% sterile aqueous solution of 
calcium-gluconate eye-drops [23], [33], [34], [45], 
although widely recommended as a preferred flushing 
agent, should be done with great care, because 
sometimes it may worsen the clinical outcome [4], 
[32].  
 Subconjunctival injection of a 1% CaG has been 
successfully used as well [25]. 
An in-vitro study revealed that 20% solution of 
mannitol used for 15 min immediately after the corneal 
HF exposure is an effective decontaminating agent 
[72]. 
According to Spöler et al. [55], Hexafluorine is 
the only decontaminating solution that preserves the 
transparency of the corneal surface, with no reported 
injuries or long-term consequences [55]. A five-year 
follow-up study revealed that chemical burns have not 
developed, nor further medical or surgical treatments 
have been needed in workers sustained an eye or 
skin HF splashes when treated with Hexafluorine [64]. 
According to Soderberg et al. [73], medical treatment 
other than initial decontamination with Hexafluorine is 
not required in workplaces where water 
decontamination followed by calcium gluconate 
injunction failed to prevent HF dermal and ocular 
burns and systemic toxicity [73]. 
One or two drops of proparacaine or 
tetracaine should provide rapid-onset ocular 
anaesthesia for 20 minutes to an hour, as severe pain 
is felt when erosion or corneal ulcer have already 
occurred. Corneal damage should be treated by an 
ophthalmologist. 
 
Treatment after HF acid ingestion 
When HF solution is ingested, it is very 
dangerous to induce vomiting. Instead, if the exposed 
person is conscious, his/her mouth should be 
thoroughly rinsed with water or with a 5-10% solution 
of calcium gluconate [9], [45].  
Gastric suction and lavage using a small 
flexible nasogastric tube are recommended within the 
first hour of ingestion [11] if a large dose of HF 
solution has been ingested or the patient has oral 
lesions or persistent oesophagal discomfort. Large 
amounts of room temperature water, milk (120-240 
ml), 10% CaG, magnesium-containing beverages (60-
120 ml) as well as 60 gr sodium polystyrene sulfonate 
should be taken orally or by nasogastric tube in order 
to dilute the acid and bind the remaining fluoride ions 
that have not been absorbed yet [9], [11], [24], [25], 
[26]. Anyway, good assessment should be done if 
using a nasogastric tube excludes the risk of 
oesophagal or gastric perforation [9].  
According to Heard and Delgado [39], oral 
administration of calcium- or magnesium-containing 
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solutions does not alter the toxic effect following 
hydrofluoric acid ingestion. It is forbidden to 
administrate sodium bicarbonate to neutralise the 
acid, as the carbon dioxide byproduct could cause 
severe burns [39]. 
Endoscopy may be performed to define the 
extent of the injury, to assess the state of mucous 
membrane and to prognosticate the course of 
recovery [11]. However, this procedure should be 
performed after the neutralisation of the HF acid 
content into the stomach, as the HF destroys optic 
fibres while attempting endoscopic examination [25]. 
 
  Treatment after HF inhalation 
After inhalation of HF gases, fumes or 
vapours, the affected person should be immediately 
moved to fresh air. One hundred per cent oxygen (10 
to 12 L/min flow rate) should be administered as soon 
as possible [45], and a bag-valve-mask for assistant 
ventilation can be used if breathing has stopped [24]. 
Calcium gluconate solution, 2.5% - 5%, given 
by intermittent positive-pressure ventilation using a 
nebuliser is the therapy of choice when starting the 
hospital treatment [17], [56]. Aerosolised 
bronchodilator should be administered in the patients 
with bronchospasm considering the myocardial 
condition; the risk of cardiac arrhythmias (especially in 
the elderly) should be estimated. Racemic 
epinephrine aerosol (0.25–0.75 mL of 2.25% racemic 
epinephrine solution in 2.5 cc water), repeated every 
20 minutes if needed, might be useful for children who 
developed stridor [5], [24]. In the case of pulmonary 
oedema, calcium gluconate and N-Acetyl cysteine 
given intravenously on the first day and with a 
nebuliser for 48 h after the exposure have been 
proved to be efficient in reducing the pulmonary 
secretion [57]. Aspiration and lavage of the affected 
bronchi [45] or lungs [3] may also be performed. 
If the respiration is compromised (in case of 
oedema, laryngospasm and hypoxemia), an airway 
may be secured via endotracheal intubation [11], [19], 
cricothyroidotomy or tracheotomy [35], [45], while the 
respiratory function should be established by 
mechanical ventilation. 
Fiberoptic bronchoscopy is a prognostic 
procedure that is performed to assess the extent of 
damage to the respiratory tract and to evaluate the 
efficacy of the conducted therapy [3]. 
 
Systemic toxicity treatment 
As mentioned before, the fluoride is a low-
molecular-weight anion that is easily absorbed 
through the skin, mucous membranes of the 
gastrointestinal and respiratory tracts, diffusing readily 
into the bloodstream causing fluorosis and acidosis, 
hypocalcemia, hypomagnesemia and hyperkalemia or 
hypokalemia [2], [61], [62]. The half-life of fluoride is 
12 to 24 hours and is eliminated primarily through 
renal excretion. Because of its highly toxic potential, 
increasing the renal elimination by administrating 
diuretic therapy and alkalization of the urine with 
sodium bicarbonate are of great importance [45]. 
Even if the serum electrolytes and blood 
saturation with oxygen are already normalised, 
recurrent ventricular fibrillation may still occur. It is 
assumed that the reason is fluoride-induced 
cardiotoxicity due to the high fluoride levels in the 
serum and urine. In such cases, hemodialysis enables 
full recovery of the intoxicated person [58]. 
Continuous renal replacement therapy, hemofiltration 
or hemodialysis, should be conducted as an effective 
and potentially lifesaving treatment in patients with 
severe systemic toxicity [23], [45], [60]. Antar-Shultz et 
al. [37], have confirmed 70% reduction of the fluoride 
level in the blood after three hours of hemodialysis, 
with the recommendation, the initial hemodialysis to 
be prolonged beyond the standard four-hour treatment 
session [37]. Continuous venovenous hemodialysis up 
to 72 hours followed by continuous venovenous 
hemofiltration up to 10 days has been performed to 
remove delayed release of fluoride ions to avoid 
fluoride-related cardiac toxicity [45]. 
According to Pu et al., “cardiac arrhythmia is 
the leading cause of death during the early stage, 
mainly due to polymorphic ventricular tachycardia and 
ventricular dysrhythmias” [45]. Hypocalcemia is 
considered as the main factor that provokes 
disturbances in the cardiac rhythm. Therefore 
calcium-containing substances are mainstays of 
therapy for fluoride toxicity [11]. Normal calcium level 
can be achieved by ordering intravenous (IV) 
infusions of 10% calcium gluconate [74], [75], [76], 
with doses of 0.1 to 0.2 mL/kg. Infusions can be 
repeated until serum calcium, ECG, or symptoms 
improve. If hand or forearm is affected, Hatzifotis et al. 
[29] recommended regional IV infusion of 40 ml 10% 
CaG with 5000 U heparin. Pu et al. [45] in a person 
with severe cutaneous injuries involving approximately 
60% of the TBSA (with third-degree burns present on 
approximately 13% of the burn area), provoked by 
10% HF and 50% nitric acid, after an initial 20mL IV 
bolus of 10% CaG, continued the infusion with 6 g/h 
until ultimate normalization of calcemia and 
stabilization of the cardiac rhythm (a total of 55g of 
CaG during the first 24 hours) [45]. A total of 8.4 gr of 
elemental calcium administered as 10% calcium 
gluconate at 20 mL/h, is a dosage that has normalised 
Ca level when ingested 120 ml of 20-25% HFA [11]. 
Intra-arterial infusion of calcium gluconate, 
firstly reported by Köhnlein and Achinger [50], is 
indicated when exposed to high HF concentrations 
with severe burns [51], rapid destruction of tissues 
and acute systemic toxicity especially in patients with 
upper and lower extremities- and facial burns [29], 
[30], [63], [77], [78]. According to ASTDR, the initial 
dosage is 10 mL of 10% calcium gluconate diluted 
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with 40 mL D5W given intra-arterially over 4 hours. If 
the pain is unrelieved, 20% concentrations should be 
used. The ultimate goal is achieving a pain-free 
condition for up to 4 hours [24]. 
Nguyen et al. [79] reported a case of calcium 
gluconate infusion via the external carotid artery in a 
person with severe face burn. When severe burns of 
the digits, the brachial or the radial artery [51], [77], 
[80] are catheterised, depending on the fingers 
involved [53]. Intra-arterial infusions of 2% CaG 
solution in 5% dextrose have been given through 
radial artery at wrist level, every four hours for 36 
hours when burned middle and fourth fingers with 
70% HF acid [51]. Pain symptoms have been 
improved and sensory, and motor functions have 
been restored in the fingers D II to D V injured with 
60% HFA, after intra-arterial infusion of 10 ml 20% 
CaG in 40 ml 0.9 % NaCl administered over 4 hours. 
Thomas et al. [63] concluded that intra-arterial calcium 
gluconate injection is a successful and well-tolerated 
therapy for HF burn of the hand associated with 
Raynaud's syndrome [63]. Vasospasm of the common 
palmar digital artery has been eliminated by 
vasoactive therapy with alprostadil while platelet 
aggregation has been inhibited with acetylsalicylic 
acid and clopidogrel [53]. 
However, a great precaution and Intensive 
Care Unit (ICU) monitoring is required when ordering 
intra-arterial infusion (in terms of infusion solution, 
concentration, and time interval) as some serious 
complications may occur including artery spasm and 
bleeding, hematomas followed by median nerve 
palsies, carpal tunnel syndrome, hypercalcemia and 
even a high morbidity when brachial artery-
cannulation [23].  
Hypomagnesemia, associated with a 
prolonged QTc and possible lethal dysrhythmias, can 
be solved by 2 to 4 mL of 50% of magnesium sulfate 
intravenously, over 40 minutes [4], [24], [61], [62], 
[74], or continuous IV infusion of 25% magnesium 
sulfate at 1.5 g/h according to the concentration of 
serum magnesium [11], [45].  
Hyperkalemia, provoking ECG disturbances 
or cardiac arrest, should be treated with calcium 
gluconate (10-20 ml of 10% solution IV) to protect 
myocardium, in conjunction with 10 U of regular 
insulin intravenously administered along with 50 mL of 
50% dextrose (or glucose) [11] to enhance shifting 
potassium from the vascular space into the cells; 10-
20 mg (5 mg/ml) Albuterol (Ventolin) administered by 
nebulizer, has additive effect to that of insulin, while 
20-40 mg Furosemide (Lasix) IV, increases renal 
excretion of potassium, thus, both of them, decreasing 
the free potassium level. Sodium bicarbonate 
administered intravenously as 8.4 % solution and 60 g 
sodium polystyrene sulfonate given via the 
nasogastric tube or in 30 ml of sorbitol solution 
administered orally (in the case of HFA ingestion), 
removes potassium from the blood or gastrointestinal 
tract in exchange for sodium [11]. 
Patients with a life-threatening condition 
(substantial skin burns, persistent hypotension, 
respiratory distress, cardiac arrhythmias, seizures and 
coma) should be admitted at an intensive care unit 
[30], and treated according to Advanced Life Support 
(ALS) protocol. 
In the case of ventricular fibrillation, 
defibrillation should be conducted, as many times as 
needed [11], [14], [45] and administrate dobutamine to 
improve left ventricular contraction. If acute respiratory 
distress syndrome (ARDS) appears, and routine 
mechanical ventilation or higher level of applied 
positive end-expiratory pressure (PEEP) cannot 
improve oxygenation, extracorporeal membrane 
oxygenation (ECMO) is a method for relief from 
hypoxemia and/or carbon dioxide retention [45], [57]. 
Additionally, glucocorticoid 
(methylprednisolone 40mg/8h) and antibiotic to 
prevent bacterial infection should be administered 
[35], [45]. 
Unfortunately, when exposed to high 
concentration of HFA solution (50% and higher), with 
extensive and deep skin burns (third-degree), even a 
vigorous medical treatment consisted of a continuous 
administration of calcium gluconate (50 ml/h, 8,5% 
solution) and magnesium sulfate, a massive 
transfusion of saline with catecholamine (vasopressor) 
for the treatment of shock, Midazolam (2 mg), 
vecuronium (8 mg), and buprenorphine (0.2 mg), 
extensive skin debridement and even leg amputation 
in order to prevent HFA flowing into systemic 
circulation, defibrillation and cardiopulmonary 
resuscitation could not stop the progression of 
disseminated intravascular coagulation that eventually 
lead to cardiopulmonary arrest, progressive organ 
damage and lethal outcome [19].  
 
 
Conclusion 
 
Due to its high reactivity, hydrofluoric acid is a 
commonly used the chemical compound in many 
industrial branches and as a domestic cleaning agent. 
It possesses corrosive potential causing burns and 
tissue necrosis on the site of contact, while when 
absorbed into the bloodstream and distributed to all 
organs and tissues, it provokes potential life-
threatening systemic toxicity and organs failure. All 
this imposes an extraordinary caution and great 
awareness of health consequences when using, and 
implementation of all personal and general protective 
measures. 
The kinetics of the fluoride ion penetration into 
the skin and mucous membrane and organ 
distribution imposes appropriate urgent first aid and 
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secondary medical management. Initial 
decontamination procedures started within the first 
minute after the exposure, neutralisation and antidote 
agents implemented promptly are of great importance 
to avoid or minimise the extent and depth of local 
tissue damage or necrosis, as well as to prevent 
absorption and systemic distribution of the fluoride 
ions and massive systemic electrolyte imbalance. 
Electrolyte replacement therapy including calcium 
gluconate and magnesium sulfate, fluid resuscitation, 
bronchodilators, glucocorticoids and antibiotics, 
vasopressors, in conjunction with insulin, furosemide 
and anticoagulants, are medicines of choice. 
Extracorporeal membrane oxygenation used to 
improve oxygenation and to support hemodynamic 
profile in case of acute respiratory distress syndrome 
or cardiac arrest, as well as renal replacement 
therapy, to remove serum fluorides and excess 
potassium, are sometimes necessary procedures to 
sustain life in severe fluoride intoxication.  
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